Aug 12 (Reuters) - iTeos Therapeutics Inc ITOS.O :
* ITEOS REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.75
* Q2 EARNINGS PER SHARE ESTIMATE $-0.41 -- REFINITIV IBES
DATA
* HAD CASH AND CASH EQUIVALENTS OF $302.9 MILLION AS OF JUNE
30,
2021, COMPARED TO $136.9 MILLION AS OF JUNE 30, 2020
* ITEOS THERAPEUTICS - BELIEVES EXISTING CASH, CASH
EQUIVALENTS
WOULD ENABLE CO TO FUND OPERATING EXPENSES, CAPITAL EXPENDITURE
REQUIREMENTS INTO 2026
Source text for Eikon: ID:nGNX6wsdh4
Further company coverage: ITOS.O
((Reuters.Briefs@thomsonreuters.com;))